Curiel and colleagues reported that the presence of high numbers of CD4+FoxP3+ T cells in malignant ascites of patients with ovarian carcinomas correlated with advanced tumor staging and reduced survival. The gene discussed is CD4; the disease is ovarian carcinoma.